FindTrial
Sign In

To compare the improvement in vision of patients with ARMD and cataract after undergoing cataract surgery with iol AMD vs Monofocal intraocular lens

Comparative evaluation of visual outcomes after implantation of iol AMD vs Monofocal intraocular lens implantation in cases with severe Age related Macular Degeneration with significant cataract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021510
Enrollment
10
Registered
2019-10-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H358- Other specified retinal disorders

Interventions

Intervention1: Phacoemulsification with iol AMD implantation: implantation of iol AMD in severe ARMD patients with cataract Control Intervention1: Phacoemulsification with monofocal intraocular lens:

Sponsors

Eyemax mono
Lead Sponsor
Prof Jeewan S Titiyal
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with bilateral intermediate to advanced dry ARMD , geographic atrophy 2) Stable neovascular type ARMD with central macular scar of > 500 micron to 1 DD 3) Patients having snellens Visual acuity of less than 6/12 to 3/60 4) Patients having significant B/l senile cataract 5) Patients who give voluntary informed written onsent to be a part of the study

Exclusion criteria

Exclusion criteria: 1) Untreated / uncontrolled neovascular ARMD 2) Untreated / uncontrolled diabetic maculopathy 3) Vision better than 6/12 4) Pseudoexfoliation syndrome 5) Fuchs endothelial dystrophy 6) Pregnancy 7) Zonular laxity 8) Prior keratorefractive surgery 9) Prior penetrating keratoplasty 10) Prior retinal detachment surgery 11) Glaucoma / Pale disc 12) Those who are not willing to be a part of the study

Design outcomes

Primary

MeasureTime frame
To compare the visual acuity post iol AMD vs Monofocal Iol implantation in patients with severe ARMD with significant cataractTimepoint: Preop and postop day 1,7,30and 90—

Secondary

MeasureTime frame
To assess patient satisfaction using Visual Function Questionairre NEI VFQ 25Timepoint: Preop and postop day 1,7,30and 90—

Countries

India

Contacts

Public ContactDr Akshaya Balaji

DR RAJENDRA PRASAD CENTRE FOR OPHTHALMIC SCIENCES

titiyal@gmail.com9810649942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026